23-valent polysaccharide pneumococcal vaccine ( DrugBank: - )

---

1 disease

ID	Disease name (Link within this page)	Number of trials
96	Crohn disease	2

96. Crohn disease

---

Clinical trials : 2,400 /  Drugs : 1,391 - (DrugBank : 267) / Drug target genes : 170 - Drug target pathways : 215

No.	TrialID	Date_ enrollment	Date_ registration	Public_title	Scientific_title	Condition	Intervention	Primary_ sponsor	Secondary_ sponsor	Recruitment_ Status	Inclusion_ agemin	Inclusion_ agemax	Inclusion_ gender	Target_ size	Phase	Countries
1	NCT01505855 (ClinicalTrials.gov)	December 2011	2/1/2012	Efficacy Study of Pneumococcal Vaccination in Crohn's Disease	Serological Response to Pneumococcal Vaccination in Crohn's Disease: A Prospective Multicenter Study	Crohn's Disease	Drug: 23-valent polysaccharide pneumococcal vaccine	Kyunghee University Medical Center	Wonju Severance Christian Hospital;Seoul National University Hospital;Asan Medical Center;Soonchunhyang University Hospital;Ewha Womans University;Kosin University Gospel Hospital;Chung-Ang University Hospital;Inje University;The Catholic University of Korea;Keimyung University Dongsan Medical Center;Korea University;Wonkwang University;Severance Hospital;Konkuk University Hospital	Completed	18 Years	N/A	Both	197	Phase 4	Korea, Republic of
2	NCT00829595 (ClinicalTrials.gov)	May 2005	23/1/2009	Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease	Pneumococcal Vaccination in Patients With Inflammatory Bowel Disease	Inflammatory Bowel Disease;Crohn Disease;Ulcerative Colitis	Biological: 23-valent polysaccharide pneumococcal vaccine (Pneumovax TM)	Cedars-Sinai Medical Center	NULL	Completed	18 Years	N/A	Both	69	N/A	United States